206P Severe cognitive effects of avapritinib: Towards a mechanistic understanding
ESMO Rare Cancers · 2026-03 · 5 · 100412
DOI: 10.1016/j.esmorc.2026.100412 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Rare Cancers, 2026-03. Verfasst von J.M. Van Sabben und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sabben, J. V., Gelderblom, H., Lebrin, F., Compter, A., Weerd, L. V. D., Heijningen, C. V., Riet, B. V., Schagen, S., Tellingen, O. V., Kuil, L., & Steeghs, N. (2026). 206P Severe cognitive effects of avapritinib: Towards a mechanistic understanding. ESMO Rare Cancers, 5, 100412. https://doi.org/10.1016/j.esmorc.2026.100412
Vancouver
Sabben JV, Gelderblom H, Lebrin F, Compter A, Weerd LVD, Heijningen CV, et al. 206P Severe cognitive effects of avapritinib: Towards a mechanistic understanding. ESMO Rare Cancers. 2026;5:100412. doi:10.1016/j.esmorc.2026.100412
BibTeX
@article{Sabben2026,
author = {Sabben, J.M. Van and Gelderblom, H. and Lebrin, F. and Compter, A. and Weerd, L. Van der and Heijningen, C. Van and Riet, B. Van and Schagen, S. and Tellingen, O. Van and Kuil, L. and Steeghs, N.},
title = {206P Severe cognitive effects of avapritinib: Towards a mechanistic understanding},
journal = {ESMO Rare Cancers},
year = {2026},
volume = {5},
pages = {100412},
doi = {10.1016/j.esmorc.2026.100412}
}
EUVIMED